Evaluation of novel trial based fusion proteins for therapeutic targeting of CD25 positive leukemic cells

dc.contributor.guide	Rama Shanker verma
dc.coverage.spatial
dc.creator.researcher	Sridevi Surapally
dc.date.accessioned	2022-11-01T11:03:15Z
dc.date.available	2022-11-01T11:03:15Z
dc.date.awarded	2019
dc.date.completed	2019
dc.date.registered	2012
dc.description.abstract	Available newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	xxii,184p.
dc.identifier.uri	http://hdl.handle.net/10603/415734
dc.language	English
dc.publisher.institution	Biotechnology
dc.publisher.place	Chennai
dc.publisher.university	Indian Institute of Technology Madras
dc.relation	157
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Developmental Biology
dc.subject.keyword	Life Sciences
dc.title	Evaluation of novel trial based fusion proteins for therapeutic targeting of CD25 positive leukemic cells
dc.title.alternative
dc.type.degree	Ph.D.